2024-09-16T17:31:22-05:00 2023-12-31 411360831 OLSEN THIELEN & CO LTD 2675 LONG LAKE ROAD ST PAUL MN 55113 990 2023-01-01 411893645 CHILDREN'S CANCER RESEARCH FUND CHIL 9528939355 1650 W 82ND ST 400 MINNEAPOLIS MN 55431 ELIZABETH ALLEN CEO 9528939355 2024-08-30 1 1 RYAN VETTRUS CPA P01243596 6514834521 2023 2024-08-08 14:25:15Z X ELIZABETH ALLEN 1650 W 82ND ST 400 MINNEAPOLIS MN 55431 19260350 0 X WWW.CHILDRENSCANCER.ORG X 1997 MN CHILDREN'S CANCER RESEARCH FUND IMPROVES THE HEALTH OF CHILDREN WITH CANCER AND THEIR FAMILIES. 22 22 55 150 0 0 18617613 17954505 0 0 247617 324486 503141 106773 19368371 18385764 4933637 5840759 0 0 4084613 4216447 105241 0 3423849 9507975 8246125 18631466 18303331 736905 82433 18165627 16414111 12384527 9968654 5781100 6445457 X CHILDREN'S CANCER RESEARCH FUND IS A NATIONAL NONPROFIT DEDICATED TO ENDING CHILDHOOD CANCER. OUR MAIN FOCUS IS TO SUPPORT THE RESEARCH OF BRIGHT SCIENTISTS ACROSS THE COUNTRY WHOSE IDEAS CAN MAKE THE GREATEST IMPACT FOR CHILDREN FIGHTING CANCER. WE ALSO FUND RESOURCES AND PROGRAMS THAT HELP KIDS AND FAMILIES AS THEY NAVIGATE THE DIFFICULT EXPERIENCE OF CANCER TREATMENT AND SURVIVORSHIP. 0 0 6423219 5840759 0 RESEARCH AND GRANTING PROGRAMS:IN 2023, CCRF AWARDED OVER $6 MILLION IN RESEARCH AND PROGRAM GRANTS DESIGNED TO FUND THE BEST, MOST INNOVATIVE RESEARCH TO ADVANCE TOWARD BREAKTHROUGH TREATMENTS FOR CHILDREN WITH CANCER, IN THESE AREAS OF FOCUS: - HARD TO TREAT CANCERS: WE PRIORITIZE RESEARCH FOR CANCERS WITH PERSISTENTLY LOW SURVIVAL RATES OR THOSE SHOWING LITTLE IMPROVEMENT OVER THE YEARS. THIS ENCOMPASSED HIGHLY AGGRESSIVE AND OFTEN FATAL CANCERS SUCH AS BRAIN TUMORS, SARCOMAS, AND CERTAIN TYPES OF LEUKEMIAS. IN 2023, WE ALLOCATED $1.3 MILLION TOWARDS A RESEARCH INITIATIVE AT CHILDREN'S HOSPITAL OF PHILADELPHIA, FOCUSING THEIR EFFORTS ON NEUROBLASTOMA. COLLABORATING WITH ORGANIZATIONS NATIONWIDE, WE CONTRIBUTED TO A $1.5 MILLION OSTEOSARCOMA SUPER GRANT AWARDED TO A RESEARCH AT NEW YORK MEDICAL COLLEGE. MOREOVER, WE PROVIDED $1.0 MILLION IN FUNDING FOR BRAIN TUMOR RESEARCH AT THE UNIVERSITY OF MINNESOTA. - SURVIVORSHIP: MANY SURVIVORS OF CHILDHOOD CANCERS GRAPPLE WITH ENDURING CONSEQUENCES OF CHEMOTHERAPY, RADIATION, OR SURGICAL INTERVENTIONS, INCLUDING HEARING IMPAIRMENT, CARDIAC ISSUES, AND INFERTILITY. FURTHER INVESTIGATION IS ESSENTIAL TO DEVELOP STRATEGIES FOR EFFECTIVELY MANAGING POST-CANCER CONDITIONS IN CHILDREN AND YOUNG-ADULTS, AIMING TO MITIGATE OR ERADICATE THESE LONG-TERM EFFECTS, PARTICULARLY CONCERNING NOVEL IMMUNE-BASED AND TARGETED THERAPIES DEVELOPED IN RECENT YEARS. NOTEWORTHY IN 2023, WE GRANTED $250,000 TO A RESEARCHER AT WASHINGTON UNIVERSITY IN ST. LOUIS, CONCENTRATING ON LONG-TERM COGNITIVE OUTCOMES IN SURVIVORS OF PEDIATRIC BRAIN TUMORS. - HEALTH DISPARITIES: DISPARITIES IN CANCER OUTCOMES AMONG CHILDREN ARE INFLUENCED BY FACTORS SUCH AS RACE, ETHNICITY, AND SOCIOECONOMIC BACKGROUND. OUR FUNDING SUPPORTS RESEARCH AIMED AT UNCOVERING THE ROOT CAUSES OF THESE DISPARITIES AND DEVISING INTERVENTIONS TO RECTIFY THEM. IN 2023, WE ALLOCATED $250,000 TO RESEARCH BEING DONE AT DANA-FARBER CANCER INSTITUTE, DEDICATED TO INVESTIGATING POVERTY-INDUCED DRUG RESISTANCE IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA (ALL). - EMERGING SCIENTISTS: WE IDENTIFY AND SUPPORT EXCEPTIONALLY SKILLED RESEARCHERS AT THE OUTSET OF THEIR CAREERS, AIDING THEM IN ESTABLISHING THEIR LABORATORIES AND CONDUCTING PRELIMINARY INVESTIGATIONS. THIS SUPPORT LAYS THE FOUNDATION FOR THEM TO SECURE THE ESSENTIAL FEDERAL GRANTS NECESSARY TO ADVANCE NOVEL THERAPIES AND POTENTIAL CURES FOR PEDIATRIC CANCERS. NOTABLY, WE GRANTED $200,000 TO RESEARCHERS AT VIRGINIA POLYTECHNIC INSTITUTE & STATE UNIVERSITY AND ST. JUDE RESEARCH HOSPITAL FOR THEIR EFFORTS FOCUSED IN OSTEOSARCOMA RESEARCH AND THE DEVELOPMENT OF TARGETED THERAPIES. - SUSTAINING PROMISING RESEARCH INITIATIVES: RECOGNIZING THE POTENTIAL OF TWO PREVIOUSLY SUPPORTED RESEARCH ENDEAVORS THAT HAVE EXHIBITED ENCOURAGING RESULTS, WE EXTENDED ADDITIONAL FUNDING TO THE INVESTIGATORS, ENABLING THEM TO CONTINUE THEIR MOMENTUM. A TOTAL OF $375,000 WAS GRANTED TO RESEARCHERS AT DANA-FARBER CANCER INSTITUTE AND UNIVERSITY OF SOUTHERN CALIFORNIA SAN FRANCISCO, SUPPORTING THEIR ONGOING INVESTIGATIONS INTO SARCOMA CANCERS AND RELAPSED LIVER CANCER. THIS EXTENSION ENSURE THE CONTINUITY AND PROGRESSION OF THEIR VITAL WORK IN THESE CRITICAL AREAS OF STUDY. 6517863 0 0 EDUCATION AND AWARENESS PROGRAM:IN ADDITION TO FUNDING RESEARCH AND OFFERING SUPPORT PROGRAMS, WE GENERATE AWARENESS ABOUT THE NEED FOR CHILDHOOD CANCER RESEARCH AND PROVIDE EDUCATIONAL RESOURCES FOR RESEARCHERS. WE REACH MILLIONS OF PEOPLE THROUGH OUR WEBSITE, DIGITAL AND SOCIAL MEDIA PLATFORMS, AND IN-KIND TELEVISION AND PRINT ADVERTISING TO SHARE THE STORIES OF KIDS, FAMILIES, AND RESEARCHERS. WE'RE ALSO PROUD TO SUPPORT THE CANCER SURVIVORSHIP CONFERENCE, THE MARK E. NESBIT LECTURESHIP IN PEDIATRIC ONCOLOGY, AND THE NORMA K.C. RAMSAY, MD, DISTINGUISHED VISITING PROFESSOR LECTURESHIP SERIES. THESE BRING NATIONALLY RECOGNIZED CHILDHOOD CANCER EXPERTS TO MINNESOTA TO SPEAK ON CURRENT SURVIVORSHIP, CLINICAL AND RESEARCH ISSUES, AS WELL AS BUILD NEW RESEARCH COLLABORATIONS. 578654 0 0 FAMILY SUPPORT PROGRAMS:OUR DEDICATED FAMILY PROGRAMS IMPROVE THE WELL-BEING OF KIDS AND FAMILIES AS THEY NAVIGATE THE DIFFICULT EXPERIENCES OF CANCER TREATMENT, SURVIVORSHIP, OR BEREAVEMENT. THESE OFFERINGS INCLUDE: - THE BIG DREAMS TOUR - A CREATIVE OUTLET THAT REDUCES ISOLATION BY LEVERAGING AR, VR, AND XR TECHNOLOGY TO PROVIDE PEDIATRIC CANCER PATIENTS AN OPPORTUNITY TO GAME TOGETHER MONTHLY AND CREATE THEIR OWN ANIMATED MUSIC VIDEO, VIDEO GAME, OR VFX VIDEO; INCLUDING COMMUNITY EVENTS WHERE THEIR CREATIONS ARE BROUGHT TO LIFE IN COLORADO, FLORIDA, MAINE, MINNESOTA, AND NEW JERSEY. - CAMP NORDEN - IN-PERSON AND VIRTUAL FIVE-DAY SUMMER CAMPS ARE DESIGNED ESPECIALLY TO MEET THE UNIQUE NEEDS OF CHILDREN WHO HAVE BEEN DIAGNOSED WITH CANCER AND SUPPORT FRIENDSHIP-BUILDING, SOLIDARITY WITH PEERS, INCREASED SELF-ESTEEM, AND A FEELING OF INDEPENDENCE. THESE CAMPS FOSTER COMMUNITY AND ELIMINATE FINANCIAL OR GEOGRAPHICAL BARRIERS TO ATTEND. 13519736 1 1 0 1 0 0 0 0 0 1 1 0 0 1 1 1 1 0 0 0 0 0 0 0 1 0 0 1 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 38 0 1 55 1 0 0 0 0 0 1 1 0 0 0 0 0 0 X 22 22 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 MN AL AR CA CT FL GA HI IL KS KY MA MD MI MA NC NH NJ NM NY OK OR PA RI SC TN UT VA WI WV X X THE ORGANIZATION 9528939355 1650 W 82ND ST 400 MINNEAPOLIS MN 55431 JEAN MACHART COO, INTERIM CEO THROUGH JUNE 40.00 X X 270944 0 23821 ELIZABETH ALLEN CEO BEGINNING JULY 40.00 X X 113942 0 4526 KENNA DOOLEY - VICE PRESIDENT OF DEVELOPMENT & DONOR RELATIONS 40.00 X 180517 0 13186 MEGAN MARTINEZ DIRECTOR OF MARKETING 40.00 X 156862 0 13081 ERIN COHEN DIRECTOR OF EVENTS & PARTNERSHIPS 40.00 X 152128 0 16075 MARY MAIDEN MUELLER TECHNOLOGY, DATA & ANALYTICS MANAGER 40.00 X 119472 0 24617 MICHELLE TUMA ACCOUNTING MANAGER 40.00 X 114761 0 23916 JOHN GOLDEN CHAIRPERSON 1.00 X X 0 0 0 ABBIE MILLER MD VICE CHAIRPERSON 1.00 X X 0 0 0 MATT HEDMAN SECRETARY 1.00 X X 0 0 0 JEN WILSON TREASURER 1.00 X X 0 0 0 SUSAN DOHERTY IMMEDIATE PAST CHAIR 1.00 X X 0 0 0 ADAM CHOE DIRECTOR 1.00 X 0 0 0 INGRID CULP DIRECTOR 1.00 X 0 0 0 PETER DOROW DIRECTOR 1.00 X 0 0 0 BARB FARRELL DIRECTOR 1.00 X 0 0 0 MEGHAN HARRIS DIRECTOR 1.00 X 0 0 0 MICHELLE JOHNSON DIRECTOR 1.00 X 0 0 0 MOLLY KINSELLA DIRECTOR 1.00 X 0 0 0 DAWN LAMM DIRECTOR 1.00 X 0 0 0 CHARLES MANZONI DIRECTOR 1.00 X 0 0 0 BETH MONSRUD DIRECTOR 1.00 X 0 0 0 GREG SOUKUP DIRECTOR 1.00 X 0 0 0 CHRIS TOPPIN DIRECTOR 1.00 X 0 0 0 CHRIS ZUPFER DIRECTOR 1.00 X 0 0 0 1108626 0 119222 8 0 1 0 THE EVENTS MOVEMENT USA 7301 OHMS LANE 355 MINNEAPOLIS MN 55439 EVENT PRODUCTION 1812500 RR DONNELLEY 7810 SOLUTION CENTER CHICAGO IL 60677 PRINTING AND MAILING 1359967 REDPATH GROUP CONSULTING 400 S 4TH ST MINNEAPOLIS MN 55415 CONSULTING 242203 SALESFORCE PO BOX 203141 DALLAS TX 75320 SOFTWARE 188416 THRIVEON INC 210 S 20TH ST NEW ULM MN 56073 IT SERVICES 166521 9 434340 17520165 1392066 17954505 172078 172078 719013 566605 152408 152408 152408 372460 434340 307981 64479 64479 OTHER INCOME 900099 42294 42294 42294 18385764 42294 0 388965 5840759 5840759 413233 235812 93344 84077 3160200 1803375 713847 642978 118093 67390 26676 24027 258593 147567 58412 52614 266328 151981 60160 54187 18244 18244 30000 30000 14969 14969 1788587 1142538 41773 604276 2725284 1514101 1 1211182 788904 659847 6059 122998 364518 216924 78416 69178 203867 116204 46232 41431 49571 28287 11198 10086 254138 145024 57407 51707 25748 14693 5816 5239 DIRECT MAIL EXPENSES 1375640 1079992 295648 FEES, LICENSES AND PERM 493326 217460 52467 223399 TRAINING AND DEVELOPMEN 151562 86489 34236 30837 VENUE AND ENTERTAINMENT 123227 51293 10489 61445 -161460 -161460 18303331 13519736 1359746 3423849 X 4921400 3408100 0 1513300 10149657 5020292 963823 3339667 2265113 1652632 67290 89688 1196136 691932 420306 504204 4095995 4622297 203443 1185331 18165627 16414111 926946 468526 11249781 8314577 207800 1185551 12384527 9968654 X 3182194 4182014 2598906 2263443 5781100 6445457 18165627 16414111 82433 581924 0 X X 0 1 X 1 0 X 4475018 21914555 21100949 18617613 17520165 83628300 4475018 21914555 21100949 18617613 17520165 83628300 83628300 56694 79454 97784 97890 172078 503900 48716 47355 40171 69543 42294 248079 84380279 2456954 0.99110 0.99210 X SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: OTHER INCOME - 2019 AMOUNT: $ 48,716. 2020 AMOUNT: $ 47,355. 2021 AMOUNT: $ 40,171. 2022 AMOUNT: $ 69,543. 2023 AMOUNT: $ 42,294. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 0 0 0 0 0 0 0 1 1197 1197 0 PART II-B, LINE 1: ESTIMATED DOLLAR AMOUNT OF STAFF HOURS SPENT ON ADVOCACY 739333 145074 884407 889385 -150052 739333 745506 143879 889385 622580 50000 72926 745506 529074 50250 43256 622580 0.00000 0.60249 0.39751 0 0 1196136 691932 504204 504204 ACCRUED INTEREST RECEIVABLE 2466 OPERATING LEASE RIGHT-OF-USE 1182865 1185331 OPERATING LEASE OBLIGATION 1185551 1185551 X 25913967 581924 6799788 7381712 18532255 14969 -161460 -146491 18385764 25249610 6799788 161460 6961248 18288362 14969 14969 18303331 PART V, LINE 4: THE PURPOSE OF THE ENDOWMENT FUNDS IS TO PROVIDE SUPPORT TO HELP ERADICATE CHILDHOOD CANCER. PART X, LINE 2: THE ORGANIZATION IS EXEMPT FROM FEDERAL AND STATE INCOME TAXES UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE. THEREFORE, THE STATEMENTS DO NOT INCLUDE A PROVISION FOR INCOME TAXES BUT IS SUBJECT TO INCOME TAX ON NET UNRELATED BUSINESS INCOME. THE ORGANIZATION REVIEWS INCOME TAX POSITIONS TAKEN OR EXPECTED TO BE TAKEN IN INCOME TAX RETURNS TO DETERMINE IF THERE ARE ANY INCOME TAX UNCERTAINTIES. THIS INCLUDES POSITIONS THAT THE ENTITY IS EXEMPT FROM INCOME TAXES OR NOT SUBJECT TO INCOME TAXES ON UNRELATED BUSINESS INCOME. THE ORGANIZATION RECOGNIZES TAX BENEFITS FROM UNCERTAIN TAX POSITIONS ONLY IF IT IS MORE LIKELY THAN NOT THAT THE TAX POSITIONS WILL BE SUSTAINED ON EXAMINATION BY TAXING AUTHORITIES, BASED ON THE TECHNICAL MERITS OF THE POSITIONS. THE ORGANIZATION HAS IDENTIFIED NO INCOME TAX UNCERTAINTIES. THE ORGANIZATION FILES INFORMATION RETURNS AS A TAX-EXEMPT ORGANIZATION. SHOULD THAT STATUS BE CHALLENGED IN THE FUTURE, ALL YEARS SINCE INCEPTION COULD BE SUBJECT TO REVIEW BY THE IRS. PART XI, LINE 4B - OTHER ADJUSTMENTS: FUNDRAISING EXPENSES -161,460. PART XII, LINE 2D - OTHER ADJUSTMENTS: FUNDRAISING EXPENSES 161,460. AL AK AZ AR CA CO CT DE DC FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA RI SC SD TN TX UT VT VA WA WV WI WY DREAM 370709 321064 49645 475 30187 209245 GOLF 404433 113276 291157 850 24385 27416 15423 1 31658 31658 806800 434340 372460 850 24385 27891 30187 224668 307981 64479 1 CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE 10900 EUCLID AVE NORD HALL 6TH FLOOR CLEVELAND OH 44106 501C3 125000 0 CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE: 2021 CCRF HTT ALEX HUANG MD FINAL PAYMENT CHILDREN'S HOSPITAL OF LOS ANGELES 4650 SUNSET BLVD LOS ANGELES CA 90027 501C3 125000 0 CHILDREN'S HOSPITAL OF LOS ANGELES: 2021 HTT PETER CHIARELLI FINAL PAYMENT CHILDREN'S HOSPITAL OF PHILADELPHIA RESEARCH INSTITUTE PO BOX 8500 PHILADELPHIA PA 19178 501C3 125000 0 CHILDREN'S HOSPITAL OF PHILADELPHIA RESEARCH INSTITUTE: 2021 CCRF SURVIVORSHIP DR LISA SCHWARTZ FINAL PAYMENT CHILDREN'S HOSPITAL OF PHILADELPHIA RESEARCH INSTITUTE PO BOX 8500 PHILADELPHIA PA 19178 501C3 125000 0 CHILDREN'S HOSPITAL OF PHILADELPHIA RESEARCH INSTITUTE: 2022 SURVIVORSHIP AWARD DR SOGOL MOSTOUFI-MOAB FIRST PAYMENT DANA-FARBER CANCER INSTITUTE INC 450 BROOKLINE AVENUE BP437 BOSTON MA 02215 501C3 125000 0 DANA-FARBER CANCER INSTITUTE, INC.: 2021 CCRF SURVIVORSHIP AWARD- DR KATIE GREENZANG FINAL PAYMENT DANA-FARBER CANCER INSTITUTE INC 450 BROOKLINE AVENUE BP437 BOSTON MA 02215 501C3 125000 0 DANA-FARBER CANCER INSTITUTE, INC.: 2022 DISPARITIES DR KIRA BONA 1ST PAYMENT FRED HUTCHINSON CANCER CENTER 1100 FAIRVIEW AVE N SEATTLE WA 98109 501C3 113361 0 FRED HUTCHINSON CANCER CENTER: 2022 RESEARCH FUND DR SOHEIL MESHINCHI 1ST PAYMENT FRED HUTCHINSON CANCER CENTER 1100 FAIRVIEW AVE N SEATTLE WA 98109 501C3 511640 0 FRED HUTCHINSON CANCER CENTER: 2022 RESEARCH FUND DR SOHEIL MESHINCHI 1ST PAYMENT LAD IN A BATTLE LLC 109 WOODBRIDGE ROAD YORK ME 03909 501C3 100000 0 LAD IN A BATTLE LLC: BIG DREAM TOUR 2 OF 2 LAD IN A BATTLE LLC 109 WOODBRIDGE ROAD YORK ME 03909 501C3 100000 0 LAD IN A BATTLE LLC: BIG DREAMS TOUR PAYMENT 1 OF 2 LEE HEALTH FOUNDATION 9800 SOUTH HEALTHPARK DRIVE FORT MYERS FL 33908 501C3 10000 0 LEE HEALTH FOUNDATION: NAPLES EVENT CONTRIBUTION TO FAMILY PROGRAMS AT GOLISANO CHILDREN'S HOSPITAL MOMCOLOGY 141 S ROSCOE BLVD PONTE VERDA BEACH FL 32082 501C3 55000 0 MOMCOLOGY: MOMCOLOGY 2ND 2023 PAYMENT MOMCOLOGY 141 S ROSCOE BLVD PONTE VERDA BEACH FL 32082 501C3 55000 0 MOMCOLOGY: PAYMENT 1 OF 2 ST BALDRICK'S FOUNDATION INC 1333 S MAYFLOWER AVE STE 400 MONROVIA CA 91016 501C3 100000 0 ST. BALDRICK'S FOUNDATION, INC: HOPE GRANT FOR DR. MITCH CAIRO ST BALDRICK'S FOUNDATION INC 1333 S MAYFLOWER AVE STE 400 MONROVIA CA 91016 501C3 103000 0 ST. BALDRICK'S FOUNDATION, INC: OSTEOSARCOMA SUPER GRANT PAYMENT 1 OF 3 ST JUDE CHILDREN'S RESEARCH HOSPITAL 262 DANNY THOMAS PL MEMPHIS TN 38105 501C3 100000 0 ST. JUDE CHILDREN'S RESEARCH HOSPITAL: 2023 EMERGING SCIENTIST DR. LILLIAN GUENTHER THE RECTOR AND VISITORS OF THE UNIVERSITY OF VIRGINIA 2022 HARD TO TREAT D PO BOX 400195 CHARLOTTESVILLE VA 22904 501C3 125000 0 THE RECTOR AND VISITORS OF THE UNIVERSITY OF VIRGINIA: 2022 HARD TO TREAT DR JOHN BUSHWELLER THE REGENTS OF THE UNIVERSITY OF CALIFORNIA PO BOX 748872 LOS ANGELES CA 90074 501C3 125000 0 THE REGENTS OF THE UNIVERSITY OF CALIFORNIA: 2021 HTT AMIT SABNIS FINAL PAYMENT UNIVERSITY OF MINNESOTA FOUNDATION 200 OAK STREET SE SUITE 500 MINNEAPOLIS MN 55455 416042488 501C3 250000 0 UNIVERSITY OF MINNESOTA FOUNDATION: GA# 090123-01 24232 KATIE HAGEBOECK UMF #25157- NK CELL THERAPY FOR MALIGNANT BRAIN TUMOR UNIVERSITY OF MINNESOTA FOUNDATION 200 OAK STREET SE SUITE 500 MINNEAPOLIS MN 55455 416042488 501C3 20914 0 UNIVERSITY OF MINNESOTA FOUNDATION: GA#02022023-1 FUND 24232 UNIVERSITY OF MINNESOTA FOUNDATION 200 OAK STREET SE SUITE 500 MINNEAPOLIS MN 55455 416042488 501C3 16446 0 UNIVERSITY OF MINNESOTA FOUNDATION: GA#02022023-3 FUND 20133 UNIVERSITY OF MINNESOTA FOUNDATION 200 OAK STREET SE SUITE 500 MINNEAPOLIS MN 55455 416042488 501C3 75000 0 UNIVERSITY OF MINNESOTA FOUNDATION: GA#022321-4 FUND 15901 PURPOSE EMERGING NEEDS/UNRESTRICTED UNIVERSITY OF MINNESOTA FOUNDATION 200 OAK STREET SE SUITE 500 MINNEAPOLIS MN 55455 416042488 501C3 200000 0 UNIVERSITY OF MINNESOTA FOUNDATION: GA#022321-4 FUND 15901 PURPOSE EMERGING SCIENTIST AWARDS UNIVERSITY OF MINNESOTA FOUNDATION 200 OAK STREET SE SUITE 500 MINNEAPOLIS MN 55455 416042488 501C3 75000 0 UNIVERSITY OF MINNESOTA FOUNDATION: GA#022321-4 FUND 15901 PURPOSE FY23 START UP PAYMENT DR. DARKO BOSNAKOVSKI UNIVERSITY OF MINNESOTA FOUNDATION 200 OAK STREET SE SUITE 500 MINNEAPOLIS MN 55455 416042488 501C3 200000 0 UNIVERSITY OF MINNESOTA FOUNDATION: GA#022321-4 FUND 15901PURPOSE MEDICAL FELLOWSHIPS UNIVERSITY OF MINNESOTA FOUNDATION 200 OAK STREET SE SUITE 500 MINNEAPOLIS MN 55455 416042488 501C3 100000 0 UNIVERSITY OF MINNESOTA FOUNDATION: GA#022321-4 FUND 15901PURPOSE: SUMMER INTERNSHIP PROGRAMS UNIVERSITY OF MINNESOTA FOUNDATION 200 OAK STREET SE SUITE 500 MINNEAPOLIS MN 55455 416042488 501C3 100000 0 UNIVERSITY OF MINNESOTA FOUNDATION: GA#022321-4 UMF#15901 FUNDING FOR ANDREW MARLEY EMERGING SCIENTIST AWARD UNIVERSITY OF MINNESOTA FOUNDATION 200 OAK STREET SE SUITE 500 MINNEAPOLIS MN 55455 416042488 501C3 100000 0 UNIVERSITY OF MINNESOTA FOUNDATION: GA#022321-4 UMF#15901 FUNDING FOR BALBO JACOBSON, MACMILLAN FACULTY AWARD UNIVERSITY OF MINNESOTA FOUNDATION 200 OAK STREET SE SUITE 500 MINNEAPOLIS MN 55455 416042488 501C3 50000 0 UNIVERSITY OF MINNESOTA FOUNDATION: GA#022321-4 UMF#15901 FUNDING FOR BEAU WEBBER, RUPIN SUN FACULTY AWARD UNIVERSITY OF MINNESOTA FOUNDATION 200 OAK STREET SE SUITE 500 MINNEAPOLIS MN 55455 416042488 501C3 100000 0 UNIVERSITY OF MINNESOTA FOUNDATION: GA#022321-4 UMF#15901 FUNDING FOR BESHAY ZORDOKY, CHRISTINA CAMELL SURVIVORSHIP AWARD UNIVERSITY OF MINNESOTA FOUNDATION 200 OAK STREET SE SUITE 500 MINNEAPOLIS MN 55455 416042488 501C3 100000 0 UNIVERSITY OF MINNESOTA FOUNDATION: GA#022321-4 UMF#15901 FUNDING FOR BRANDEN MORIARITY FACULTY AWARD UNIVERSITY OF MINNESOTA FOUNDATION 200 OAK STREET SE SUITE 500 MINNEAPOLIS MN 55455 416042488 501C3 100000 0 UNIVERSITY OF MINNESOTA FOUNDATION: GA#022321-4 UMF#15901 FUNDING FOR BRUCE BLAZAR FACULTY AWARD UNIVERSITY OF MINNESOTA FOUNDATION 200 OAK STREET SE SUITE 500 MINNEAPOLIS MN 55455 416042488 501C3 100000 0 UNIVERSITY OF MINNESOTA FOUNDATION: GA#022321-4 UMF#15901 FUNDING FOR DARKO BOSNAKOVSKI FACULTY AWARD UNIVERSITY OF MINNESOTA FOUNDATION 200 OAK STREET SE SUITE 500 MINNEAPOLIS MN 55455 416042488 501C3 100000 0 UNIVERSITY OF MINNESOTA FOUNDATION: GA#022321-4 UMF#15901 FUNDING FOR EBENS, BOULL, NIEDERNHOFER, TOTAL FACULTY AWARD UNIVERSITY OF MINNESOTA FOUNDATION 200 OAK STREET SE SUITE 500 MINNEAPOLIS MN 55455 416042488 501C3 100000 0 UNIVERSITY OF MINNESOTA FOUNDATION: GA#022321-4 UMF#15901 FUNDING FOR ERIN MARCOTTE FACULTY AWARD UNIVERSITY OF MINNESOTA FOUNDATION 200 OAK STREET SE SUITE 500 MINNEAPOLIS MN 55455 416042488 501C3 100000 0 UNIVERSITY OF MINNESOTA FOUNDATION: GA#022321-4 UMF#15901 FUNDING FOR ERIN MARCOTTE, LUCIE TURCOTTE FACULTY AWARD UNIVERSITY OF MINNESOTA FOUNDATION 200 OAK STREET SE SUITE 500 MINNEAPOLIS MN 55455 416042488 501C3 100000 0 UNIVERSITY OF MINNESOTA FOUNDATION: GA#022321-4 UMF#15901 FUNDING FOR GUPTA, GOLDFARB, SADAK, HENEGHAN FACULTY AWARD UNIVERSITY OF MINNESOTA FOUNDATION 200 OAK STREET SE SUITE 500 MINNEAPOLIS MN 55455 416042488 501C3 100000 0 UNIVERSITY OF MINNESOTA FOUNDATION: GA#022321-4 UMF#15901 FUNDING FOR JEMMA LARSON EMERGING SCIENTIST AWARD UNIVERSITY OF MINNESOTA FOUNDATION 200 OAK STREET SE SUITE 500 MINNEAPOLIS MN 55455 416042488 501C3 100000 0 UNIVERSITY OF MINNESOTA FOUNDATION: GA#022321-4 UMF#15901 FUNDING FOR LINDSAY WILLIAMS FACULTY AWARD UNIVERSITY OF MINNESOTA FOUNDATION 200 OAK STREET SE SUITE 500 MINNEAPOLIS MN 55455 416042488 501C3 100000 0 UNIVERSITY OF MINNESOTA FOUNDATION: GA#022321-4 UMF#15901 FUNDING FOR LINDSAY WILLIAMS, TAINZHONG YANG FACULTY AWARDS UNIVERSITY OF MINNESOTA FOUNDATION 200 OAK STREET SE SUITE 500 MINNEAPOLIS MN 55455 416042488 501C3 100000 0 UNIVERSITY OF MINNESOTA FOUNDATION: GA#022321-4 UMF#15901 FUNDING FOR MARK OSBORN FACULTY AWARDS UNIVERSITY OF MINNESOTA FOUNDATION 200 OAK STREET SE SUITE 500 MINNEAPOLIS MN 55455 416042488 501C3 100000 0 UNIVERSITY OF MINNESOTA FOUNDATION: GA#022321-4 UMF#15901 FUNDING FOR MORIARITY, WAGNER, FACULTY AWARD UNIVERSITY OF MINNESOTA FOUNDATION 200 OAK STREET SE SUITE 500 MINNEAPOLIS MN 55455 416042488 501C3 100000 0 UNIVERSITY OF MINNESOTA FOUNDATION: GA#022321-4 UMF#15901 FUNDING FOR TROY LUND, PETER GORDON FACULTY AWARD UNIVERSITY OF MINNESOTA FOUNDATION 200 OAK STREET SE SUITE 500 MINNEAPOLIS MN 55455 416042488 501C3 100000 0 UNIVERSITY OF MINNESOTA FOUNDATION: GA#022321-4 UMF#15901 FUNDING FOR WEBBER, WILLIAMS, GORDON FACULTY AWARDS UNIVERSITY OF MINNESOTA FOUNDATION 200 OAK STREET SE SUITE 500 MINNEAPOLIS MN 55455 416042488 501C3 100000 0 UNIVERSITY OF MINNESOTA FOUNDATION: GA#022321-4 UMF#15901FUNDING FOR CINDY IM, CHRISTINA BOULL SURVIVORSHIP AWARD UNIVERSITY OF MINNESOTA FOUNDATION 200 OAK STREET SE SUITE 500 MINNEAPOLIS MN 55455 416042488 501C3 112697 0 UNIVERSITY OF MINNESOTA FOUNDATION: GA#032922-3 UMF FUND #24232 KATIE HAGEBOECK CLINIC PURPOSE: SURVIVORSHIP CARE AND RESEARCH UNIVERSITY OF MINNESOTA FOUNDATION 200 OAK STREET SE SUITE 500 MINNEAPOLIS MN 55455 416042488 501C3 700000 0 UNIVERSITY OF MINNESOTA FOUNDATION: GA#032922-3 UMF FUND #24232 KATIE HAGEBOECK CLINIC PURPOSE: SURVIVORSHIP CARE AND RESEARCH UNIVERSITY OF MINNESOTA FOUNDATION 200 OAK STREET SE SUITE 500 MINNEAPOLIS MN 55455 416042488 501C3 650000 0 UNIVERSITY OF MINNESOTA FOUNDATION: GA#032922-5 FUND 24231-KATIE HAGEBOECK CLINIC FUND CAPITAL FUNDING UNIVERSITY OF MINNESOTA FOUNDATION 200 OAK STREET SE SUITE 500 MINNEAPOLIS MN 55455 416042488 501C3 250000 0 UNIVERSITY OF MINNESOTA FOUNDATION: GA#090123-01 UMF#25157 NK CELL THERAPY FOR MALIGNANT BRAIN TUMOR PROJECT FUND 22000 UNIVERSITY OF MINNESOTA FOUNDATION 200 OAK STREET SE SUITE 500 MINNEAPOLIS MN 55455 416042488 501C3 125000 0 UNIVERSITY OF MINNESOTA FOUNDATION: GA#090123-02 NEUROFIBROMATOSIS MALIGNANT PERIPHERAL NERVE SHEATH PROJECT FUND 22000 BRAIN TUMOR RESEARCH UNIVERSITY OF MINNESOTA FOUNDATION 200 OAK STREET SE SUITE 500 MINNEAPOLIS MN 55455 416042488 501C3 125000 0 UNIVERSITY OF MINNESOTA FOUNDATION: GA#090123-02 UMF FUND 24232 KATIE HAGEBOECK UMF PURPOSE NEUROFIBROMATOSIS MALIGNANT PERIPHERAL NERVE SHEATH PROJECT UNIVERSITY OF MINNESOTA FOUNDATION 200 OAK STREET SE SUITE 500 MINNEAPOLIS MN 55455 416042488 501C3 125000 0 UNIVERSITY OF MINNESOTA FOUNDATION: GA#090123-03 UMF FUND 24232 KATIE HAGEBOECK CLINIC UMF #25159 NEUROFIBROMATOSIS NUTRACEUTICAL UNIVERSITY OF MINNESOTA FOUNDATION 200 OAK STREET SE SUITE 500 MINNEAPOLIS MN 55455 416042488 501C3 125000 0 UNIVERSITY OF MINNESOTA FOUNDATION: GA#09123-03 UMF FUND#25159- NEUROFIBROMATOSIS NUTRACEUTICAL RESEARCH PROJECT FUND 22000 BRAIN TUMOR RESEARCH UNIVERSITY OF MINNESOTA FOUNDATION 200 OAK STREET SE SUITE 500 MINNEAPOLIS MN 55455 416042488 501C3 8954 0 UNIVERSITY OF MINNESOTA FOUNDATION: GA#123122-1 THRU 21 UNIVERSITY OF MINNESOTA FOUNDATION 200 OAK STREET SE SUITE 500 MINNEAPOLIS MN 55455 416042488 501C3 25000 0 UNIVERSITY OF MINNESOTA FOUNDATION: GA#123122-13 22250 RESEARCH DR SPECTOR UNIVERSITY OF MINNESOTA FOUNDATION 200 OAK STREET SE SUITE 500 MINNEAPOLIS MN 55455 416042488 501C3 113749 0 UNIVERSITY OF MINNESOTA FOUNDATION: GA#123122-14 23101 KATIE HAGEBOECK SURVIVORSHIP UNIVERSITY OF MINNESOTA FOUNDATION 200 OAK STREET SE SUITE 500 MINNEAPOLIS MN 55455 416042488 501C3 25000 0 UNIVERSITY OF MINNESOTA FOUNDATION: GA#123122-17 22080 HODDER CHAIR UNIVERSITY OF MINNESOTA FOUNDATION 200 OAK STREET SE SUITE 500 MINNEAPOLIS MN 55455 416042488 501C3 16382 0 UNIVERSITY OF MINNESOTA FOUNDATION: GA#123122-19 23810 BENEFACTOR FUND UNIVERSITY OF MINNESOTA FOUNDATION 200 OAK STREET SE SUITE 500 MINNEAPOLIS MN 55455 416042488 501C3 50000 0 UNIVERSITY OF MINNESOTA FOUNDATION: GA#123122-2 22000 BRAIN TUMOR DR SAYDAM UNIVERSITY OF MINNESOTA FOUNDATION 200 OAK STREET SE SUITE 500 MINNEAPOLIS MN 55455 416042488 501C3 98760 0 UNIVERSITY OF MINNESOTA FOUNDATION: GA#123122-20 23800 DAWN OF A DREAM FUND UNIVERSITY OF MINNESOTA FOUNDATION 200 OAK STREET SE SUITE 500 MINNEAPOLIS MN 55455 416042488 501C3 28901 0 UNIVERSITY OF MINNESOTA FOUNDATION: GA#123122-3 UNIVERSITY OF MINNESOTA FOUNDATION 200 OAK STREET SE SUITE 500 MINNEAPOLIS MN 55455 416042488 501C3 214901 0 UNIVERSITY OF MINNESOTA FOUNDATION: GA#123122-5 OSTEOSARCOMA DR. BEAU WEBBER UNIVERSITY OF MINNESOTA FOUNDATION 200 OAK STREET SE SUITE 500 MINNEAPOLIS MN 55455 416042488 501C3 20000 0 UNIVERSITY OF MINNESOTA FOUNDATION: GA#123122-6 22180 STEM CELL RESEARCH DR WAGNER UNIVERSITY OF MINNESOTA FOUNDATION 200 OAK STREET SE SUITE 500 MINNEAPOLIS MN 55455 416042488 501C3 78205 0 UNIVERSITY OF MINNESOTA FOUNDATION: GA#123122-7 22255 CELL, GENE & IMMUNOTHERAPY DR WAGNER UNIVERSITY OF MINNESOTA FOUNDATION 200 OAK STREET SE SUITE 500 MINNEAPOLIS MN 55455 416042488 501C3 148756 0 UNIVERSITY OF MINNESOTA FOUNDATION: GA#123122-8 22256 CGI EQUIP UNIVERSITY OF MINNESOTA FOUNDATION 200 OAK STREET SE SUITE 500 MINNEAPOLIS MN 55455 416042488 501C3 51079 0 UNIVERSITY OF MINNESOTA FOUNDATION: GA#123122-9 22080 EWING SARCOM DR BEAU WEBBER UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER 1515 HOLCOMBE BOULEVARD HOUSTON TX 77030 501C3 125000 0 UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER: 2021 HTT EUGENIE KLEINERMAN MD FINAL PAYMENT VIRGINIA COMMONWEALTH UNIVERSITY 800 EAST LEIGH ST SUITE 3100 RICHMOND VA 23298 501C3 125000 0 VIRGINIA COMMONWEALTH UNIVERSITY: 2021 HTT ANOTHONY FABER FINAL PAYMENT VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY 300 TURNER ST NW BLACKSBURG VA 24061 501C3 100000 0 VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY: 2022 EMERGING SCIENTIST AWARD- DR JIA-RAY YU WASHINGTON UNIVERSITY 700 ROSEDALE AVENUE ST LOUIS MO 63112 501C3 125000 0 WASHINGTON UNIVERSITY: 2023 SURVIVORSHIP AWARD DR. STEPHANIE PERKINS WEILL CORNELL MEDICAL COLLEGE 1300 YORK AVENUE BOX 314 NEW YORK NY 10065 501C3 125000 0 WEILL CORNELL MEDICAL COLLEGE: 2022 HARD TO TREAT DR. JEFFREY GREENFIELD- 1ST OF 2 PAYMENTS 17 1 PART I, LINE 2: THE ORGANIZATION PROVIDES FUNDS TO THE UNIVERSITY OF MINNESOTA AND OTHER RESEARCH HOSPITALS FOR RESEARCH AND TRAINING RELATING TO THE PREVENTION, TREATMENT AND CURE OF CHILDHOOD CANCER. THE BOARD OF DIRECTORS AND EXECUTIVE COMMITTEE MONITOR THE USE OF GRANT FUNDS. X X X X 0 0 0 0 0 0 0 0 0 JEAN MACHART COO, INTERIM CEO THROUGH JUNE 270944 0 0 0 0 0 9000 0 14821 0 294765 0 0 0 KENNA DOOLEY - VICE PRESIDENT OF DEVELOPMENT & DONOR RELATIONS 180517 0 0 0 0 0 5154 0 8032 0 193703 0 0 0 MEGAN MARTINEZ DIRECTOR OF MARKETING 156862 0 0 0 0 0 5840 0 7241 0 169943 0 0 0 ERIN COHEN DIRECTOR OF EVENTS & PARTNERSHIPS 152128 0 0 0 0 0 6085 0 9990 0 168203 0 0 0 X 48 1392066 US STOCK EXCHANGE 0 0 0 FORM 990, PART VI, SECTION A, LINE 1A EXECUTIVE COMMITTEE: CCRF HAS AN EXECUTIVE COMMITTEE WHICH CONSISTS OF THE CHAIRPERSON, THE VICE CHAIRPERSON, THE VICE CHAIRPERSON ELECT, THE TREASURER, AND THE SECRETARY. THE CHAIRPERSON MAY ALSO APPOINT SUCH OTHER MEMBERS OF THE BOARD OF DIRECTORS TO THE EXECUTIVE COMMITTEE AS HE OR SHE DETERMINES APPROPRIATE. THE EXECUTIVE COMMITTEE SHALL HAVE THE POWERS TO ACT FOR AND ON BEHALF OF THE BOARD OF DIRECTORS DURING THE PERIODS BETWEEN MEETINGS OF THE BOARD OF DIRECTORS TO TAKE ANY ACT THAT MAY BE TAKEN BY THE BOARD OF DIRECTORS. THE EXECUTIVE COMMITTEE SHALL MEET AT REGULAR INTERVALS THROUGHOUT THE YEAR. THE CEO SHALL ATTEND THE MEETINGS OF THE EXECUTIVE COMMITTEE AS A NONVOTING PARTICIPANT. THE CORPORATION MAY EXCLUDE THE CEO FROM MEETINGS OF THE EXECUTIVE COMMITTEE OR ANY PORTION OF A MEETING OR FROM ACCESS TO RELATED MATERIALS. IN THE ABSENCE OF A NOMINATING COMMITTEE, THE EXECUTIVE COMMITTEE SHALL FULFILL THE PURPOSES OF THE NOMINATING COMMITTEE. FORM 990, PART VI, SECTION B, LINE 11B THE FINANCE, INVESTMENT & ADMINISTRATION COMMITTEE REVIEWS THE FORM 990 AND RECOMMENDS ITS APPROVAL TO THE EXECUTIVE COMMITTEE. THE BOARD OF DIRECTORS RECEIVES A COPY OF THE 990 FORM BEFORE IT IS FILED. FORM 990, PART VI, SECTION B, LINE 12C ALL BOARD OF DIRECTORS AND EMPLOYEES ARE REQUIRED TO REVIEW THE CONFLICT OF INTEREST POLICY AND SIGN AN ANNUAL DISCLOSURE STATEMENT. ALL FINANCIAL TRANSACTIONS AND CONTRACTS ARE REVIEWED BY THE DIRECTOR OF FINANCE AND, IF NECESSARY, THE CEO AND ATTORNEYS TO ENSURE NO TRANSACTIONS ARE EXECUTED THAT COULD BE INTERPRETED AS INTRODUCING A CONFLICT OF INTEREST. FORM 990, PART VI, SECTION B, LINE 15 ANNUALLY, THE EXECUTIVE COMMITTEE REVIEWS THE CEO'S COMPENSATION AND RECOMMENDS A SPECIFIC LEVEL OF COMPENSATION. A COMPREHENSIVE COMPENSATION STUDY FOR ALL ORGANIZATIONAL POSITIONS IS PERFORMED PERIODICALLY, WHICH COMPARES SALARIES FOR EACH JOB DESCRIPTION RELATIVE TO GEOGRAPHIC LOCATION, ORGANIZATIONAL SIZE AND TYPE. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION'S FINANCIAL STATEMENTS ARE AVAILABLE TO THE PUBLIC ON OUR WEBSITE. THE GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY CAN ALSO BE PROVIDED UPON REQUEST. FORM 990, PART XII, LINE 2C: THE PROCESS HAS NOT CHANGED FROM THE PRIOR YEAR.